QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$39.12 USD
+0.86 (2.25%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $39.12 0.00 (0.00%) 6:40 PM ET
5-Strong Sell of 5 5
A Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$39.12 USD
+0.86 (2.25%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $39.12 0.00 (0.00%) 6:40 PM ET
5-Strong Sell of 5 5
A Value D Growth C Momentum C VGM
Zacks News
Has Quidel (QDEL) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (QDEL) Outperforming Other Medical Stocks This Year?
Why the Earnings Surprise Streak Could Continue for Quidel (QDEL)
by Zacks Equity Research
Quidel (QDEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Top Ranked Momentum Stocks to Buy for October 6th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 6th
7 Diagnostic and Genomic Stocks Storming Into October
by Kevin Cook
COVID-19 has created an Apollo Mission status for advanced medical technologies and smart investors are profiting.
AngioDynamics (ANGO) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
AngioDynamics (ANGO) witnessed revenue growth across two business segments in fiscal Q1.
Quidel (QDEL) Stock Moves -1.39%: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed at $196.21 in the latest trading session, marking a -1.39% move from the prior day.
NEOGEN (NEOG) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
NEOGEN's (NEOG) segmental revenues improve for the fiscal first quarter on strong sales of cleaners, disinfectants and sanitizers.
Rockwell Medical (RMTI) Soars: Stock Adds 9.7% in Session
by Zacks Equity Research
Rockwell Medical (RMTI) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Is Quidel (QDEL) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (QDEL) Outperforming Other Medical Stocks This Year?
Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed the most recent trading day at $159.39, moving -1.12% from the previous trading session.
The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Quidel, QIAGEN and Thermo Fisher Scientific
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Quidel, QIAGEN and Thermo Fisher Scientific
Quidel Enters Oversold Territory
by Zacks Equity Research
Quidel has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Coronavirus Test Makers With Scope to Maximize Investor Benefits
by Urmimala Biswas
The surge in new coronavirus infections broadens the scope for antigen and antibody tests.
Omeros (OMER) Catches Eye: Stock Jumps 6%
by Zacks Equity Research
Omeros (OMER) saw a big move last session, as its shares jumped 6% on the day, amid huge volumes.
Top Stock Picks for Week of September 8, 2020
by Panel Of Zacks Experts
Take a look at our expert's weekly picks which include Quidel (QDEL) and American Woodwork (AMWD).
Is Quidel (QDEL) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (QDEL) Outperforming Other Medical Stocks This Year?
Surface Oncology (SURF) Looks Good: Stock Adds 9.8% in Session
by Zacks Equity Research
Surface Oncology (SURF) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
The Zacks Analyst Blog Highlights: Abbott Lab, Quidel, Becton, Dickinson and Company, Hologic and Quest Diagnostics
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Abbott Lab, Quidel, Becton, Dickinson and Company, Hologic and Quest Diagnostics
Price War in Coronavirus Test Space to Intensify Thanks to Abbott
by Urmimala Biswas
Most rapid antigen tests in the United States require an additional system, which is making the procedures more costly and complex.
7 Top-Ranked Corporate Giants With More Than 50% Return YTD
by Nalak Das
A handful of corporate giants (market capital > $10 billion) have skyrocketed this year, braving the pandemic and its impact on businesses.
Has Quidel (QDEL) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (QDEL) Outperforming Other Medical Stocks This Year?
Should iShares Morningstar SmallCap Growth ETF (JKK) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JKK
Bull of the Day: Quidel (QDEL)
by Kevin Cook
Multiple FDA approvals for new 15-minute COVID-19 antigen tests have estimates and shares rising sharply
Quidel's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Quidel.
ICU Medical (ICUI) Looks Good: Stock Adds 8.1% in Session
by Zacks Equity Research
ICU Medical (ICUI) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.